SCHEMBL2933802

SCHEMBL2933802

Cc1cc(C)c(C)c(S(N)(=O)=O)c1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.47
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
LMNA P02545 2/20 0.41
GAA P10253 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
CA1 P00915 5/20 0.41
CA2 P00918 5/20 0.41
CA12 O43570 4/20 0.41
CA7 P43166 4/20 0.41
CA13 Q8N1Q1 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP19A1 P11511 1/20 0.40
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2932203 0.85 RAB9A (0.53) RAB9AKMT2AMEN1LMNAGAA
SCHEMBL27376285 0.80 RAB9A (0.39) RAB9AKMT2AMEN1LMNAGAA
SCHEMBL28958792 0.78 PTGS2 (0.57) HTTCA1CA2CA12CA7
SCHEMBL1694754 0.77 CA1 (0.43) RAB9ALMNACA1CA2CA12
SCHEMBL2929807 0.77 CA2 (0.41) RAB9ALMNAGAACA1CA2
SCHEMBL6586893 0.77 ALDH1A1 (0.48) RAB9ALMNAMAPK1CA1CA2
SCHEMBL30851364 0.75 LMNA (0.43) RAB9ALMNACA1CA2CA12
SCHEMBL8415193 0.74 CA2 (0.43) RAB9ALMNAGAACA1CA2
SCHEMBL113366 0.74 CA1 (0.52) LMNAGAACA1CA2CA12
SCHEMBL2864849 0.74 LMNA (0.46) KMT2AMEN1LMNAGAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119219810-A Ionic polymer and preparation method and application thereof 佛山绿动氢能科技有限公司 2024-12-31 CN claimed
EP-2229395-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-09-22 EP claimed
WO-2009090054-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2009-07-23 WO claimed
US-12529108-B2 Compositions, methods and kits for characterizing and screening for small cell ovarian carcinoma THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (US) 2026-01-20 US disclosed
CN-119638931-A Janus covalent organic framework membrane with synergistic coordination enhancement and preparation method and application thereof 四川大学 2025-03-18 CN disclosed
CN-116640242-B Catalyst for low-pressure olefin polymerization and preparation method and application thereof 安庆师范大学 2025-01-28 CN disclosed
CN-119219809-A Fluorine-containing polymer, preparation method thereof and ion exchange membrane 佛山绿动氢能科技有限公司 2024-12-31 CN disclosed
CN-119219810-A Ionic polymer and preparation method and application thereof 佛山绿动氢能科技有限公司 2024-12-31 CN disclosed
CN-117680100-B COF (chip on film) derivative functionalized porous carbon microsphere solid phase extractant as well as preparation method and application thereof 四川大学 2024-04-02 CN disclosed
CN-117680100-A COF (chip on film) derivative functionalized porous carbon microsphere solid phase extractant as well as preparation method and application thereof 四川大学 2024-03-12 CN disclosed
CN-116640242-A Catalyst for low-pressure olefin polymerization and preparation method and application thereof 安庆师范大学 2023-08-25 CN disclosed
EP-3892610-B1 SULFUR (VI) FLUORIDE COMPOUNDS AND THEIR USE IN CLICK-REACTION SCRIPPS RESEARCH INST (US) 2023-08-16 EP disclosed
CN-116297351-A Ratio sensor based on UiO-66-NH2@TpTtT-COF composite material and preparation method thereof 河北大学 2023-06-23 CN disclosed
US-20230145565-A1 SEMICONDUCTOR DEVICE SHINKO ELECTRIC INDUSTRIES CO., LTD. (JP) 2023-05-11 US disclosed
CN-109563509-B Reduced size self-delivering nucleic acid compounds targeting long non-coding RNAs 菲奥医药公司 2022-08-09 CN disclosed
CN-108611384-B Process for large scale enzymatic synthesis of oligosaccharides 台湾地区“中央研究院” 2022-02-25 CN disclosed
EP-3892610-A1 SULFUR (VI) FLUORIDE COMPOUNDS AND THEIR USE AS SCREENING AGENT The Scripps Research Institute (US) 2021-10-13 EP disclosed
US-20170196985-A1 SULFUR(VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF THE SCRIPPS RESEARCH INSTITUTE 2017-07-13 US disclosed
EP-2229395-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-09-22 EP disclosed
WO-2009090054-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2009-07-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170196985-A1 SULFUR(VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF CYP2F1, NAF1, CYP2S1 RAB9A 1360/4885KMT2A 2082/4885MEN1 320/4885
US-12529108-B2 Compositions, methods and kits for characterizing and screening for small cell ovarian carcinoma SMCHD1, HDAC4, SMC4 RAB9A 4183/4885KMT2A 25/4885MEN1 1091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.